As we know, cardiovascular disease remains the leading cause of death worldwide. Cardiotoxicity, as its name suggests, refers to toxicity to the heart. It is largely caused by chemotherapy and radiation therapy. The toxicity comes from the damage certain drugs or radiation cause to the myocytes, the heart’s muscle cells, leading to weaker contraction. We can distinguish two types of damage and drugs. First, those that cause irreversible damage to the myocyte, generally caused by drugs known as anthracyclines and taxanes. Second, another group of drugs causes damage that is reversible once they are stopped; these are usually anti-HER2 drugs, such as trastuzumab or pertuzumab.
As we’ve mentioned, cardiovascular disease remains the leading cause of death, not only in the general population but also among breast cancer survivors (Bradshaw PT et al., 2016). That’s why monitoring for possible cardiotoxicity is essential both during and after treatment.
In this article we want to discuss the benefits of aerobic exercise and how it may modulate cardiotoxicity. Its benefits on cardiotoxicity have not yet been studied in humans, but based on studies in rats, aerobic exercise appears quite promising. Several studies have shown that aerobic exercise can positively modulate certain genes that chemotherapy modulates negatively, causing cardiotoxicity. Aerobic exercise has been shown to increase VEGF (vascular endothelial growth factor) and endothelial differentiation (Scott JM et al., 2013). Other studies have found that short bouts of exercise during doxorubicin treatment reduce oxidative stress and thereby provide cardioprotection (Ashraf J et al., 2012).
As we can see, exercise has major benefits for cardiotoxicity, at least in rats. But if we look at the scientific evidence on its benefits for overall health, we’ll see that it regulates many of the cardiovascular problems these patients may face in the future. These include: lower blood pressure, lower resting heart rate, better endothelial function, improved VO2 max, and more (Golbidi S et al., 2012).
Regarding that last point, we want to highlight something very important. VO2 max correlates not only with cardiovascular health but is also considered a predictor of life expectancy and overall health. It is probably the most relevant biomarker of the cardiovascular system and of our functional capacity. The higher our VO2 max, the healthier and more functional we are. It also declines naturally with age, which is why aerobic exercise helps us maintain it or slow its decline.
We know that 1 in 3 women who have survived breast cancer are at the minimum VO2 max threshold (15 ml/kg/min). This means higher levels of fatigue, worse quality of life, greater dependence, worse body composition and a higher risk of all-cause mortality (Burnett D et al., 2013). That’s why cardio and strength training are seen as fundamental for improving this variable. As exercise physiologist Karlman Wasserman teaches in his gears diagram (Image 1), to improve our VO2 max and aerobic capacity we need to improve three gears: the heart, the lungs and, finally, the muscle and its mitochondria, which produce ATP and energy. To achieve this, we need to combine both types of exercise to get the greatest health benefits.
To conclude, I encourage you to start an exercise program whatever your condition. You should first consult a qualified cardiologist who can carry out any diagnostic tests they consider appropriate to make sure you’re ready to start an exercise program. At our center, we work with a multidisciplinary team that helps us take all these measures before starting our exercise programs.
REFERENCES:
- Bradshaw PT, Stevens J, Khankari N, Teitelbaum SL, Neugut AI, Gammon MD. Cardiovascular Disease Mortality Among Breast Cancer Survivors. Epidemiology. 2016 Jan;27(1):6-13. doi: 10.1097/EDE.0000000000000394.
- Scott JM, Lakoski S, Mackey JR, Douglas PS, Haykowsky MJ, Jones LW. The potential role of aerobic exercise to modulate cardiotoxicity of molecularly targeted cancer therapeutics. Oncologist. 2013;18(2):221-31. doi: 10.1634/theoncologist.2012-0226. Epub 2013 Jan 18.
- Ashraf J, Roshan VD. Is short-term exercise a therapeutic tool for improvement of cardioprotection against DOX-induced cardiotoxicity? An experimental controlled protocol in rats. Asian Pac J Cancer Prev. 2012;13(8):4025-30.
- Burnett D, Kluding P, Porter C, Fabian C, Klemp J. Cardiorespiratory fitness in breast cancer survivors. Springerplus. 2013 Dec;2(1):68. doi: 10.1186/2193-1801-2-68. Epub 2013 Feb 25.

